≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Haemolytic-uraemic syndrome

DOID EFO Endpoint Browser PheWeb

D3_NONAIHA_OTHER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D59.3
  • Hospital discharge: ICD-9 — 2831C
  • Cause of death: ICD-10 — D59.3
  • Cause of death: ICD-9 — 2831C

2 out of 7 registries used, show all original rules.

90

4. Check minimum number of events

None

90

5. Include endpoints

None

90

6. Filter based on genotype QC (FinnGen only)

90

Control definitions (FinnGen only)

Control exclude
D3_HAEMOLYTICANAEMIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D59
Name in latin
Syndroma haemolytico-uraemicum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 569 325 242
Only index persons 445 258 187
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 25.46 26.20 24.21
Only index persons 25.69 26.59 24.44

-FinnGen-

Key figures

All Female Male
Number of individuals 90 50 40
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 38.71 31.64 47.55

-FinRegistry-

Age distribution of first events

01020304050607080020406080100120140160180200AgeIndividuals

-FinnGen-

Age distribution of first events

0102030405060700246810121416AgeIndividuals

-FinRegistry-

Year distribution of first events

1970197519801985199019952000200520102015202020220102030405060708090100110120130YearIndividuals

-FinnGen-

Year distribution of first events

197019751980198520002005201020152020202302468101214161820YearIndividuals

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
81
Matched controls
808
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
+∞
61.5
51
*
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
+∞
54.4
46
*
TK800
NOMESCO Finland
Hemodialysis
574.9
37.1
34
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
191.1
34.8
34
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
518.3
34.7
32
*
A11CC03
ATC
alfacalcidol; systemic
210.1
28.7
28
*
Z94.0
ICD-10 Finland
Kidney transplant status
376.0
27.5
26
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
355.2
26.3
25
*
127
Kela drug reimbursment
Transplant complication
99.3
25.7
27
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
335.1
25.1
24
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
315.7
24.0
23
*
L04AA06
ATC
mycophenolic acid; systemic
75.2
23.8
26
5
A12AA04
ATC
calcium carbonate; oral
111.6
23.1
24
*
N18.0
ICD-10 Finland
End-stage renal disease
+∞
23.0
21
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
158.0
22.9
23
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
31.4
22.0
29
14
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
278.8
21.7
21
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
92.9
19.8
21
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
244.3
19.4
19
*
WW400
NOMESCO Finland
Plasmaferesis
+∞
17.3
16
*
B03XA02
ATC
darbepoetin alfa; parenteral
211.9
17.2
17
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.9
17.0
39
69
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
106.2
16.3
17
*
V03AE01
ATC
polystyrene sulfonate; oral
106.2
16.3
17
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
106.2
16.3
17
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
16.2
15
*
137
Kela drug reimbursment
Uraemia requiring dialysis
196.4
16.1
16
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
15.6
16.1
27
25
N18.8
ICD-10 Finland
Other chronic renal failure
45.5
15.2
18
5
B03XA01
ATC
erythropoietin; parenteral
181.4
15.0
15
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
26.0
14.7
20
10
C09AA02
ATC
enalapril; systemic
8.4
14.1
35
67
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
166.8
13.9
14
*
C08CA01
ATC
amlodipine; oral
6.5
13.5
45
130
KA1AE
NOMESCO Finland
Kidney ultrasound examination
60.5
13.4
15
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
+∞
12.8
12
*
V03AE02
ATC
sevelamer; oral
+∞
12.8
12
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
28.0
12.1
16
7
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
11.7
11
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
11.7
11
*
C02AC05
ATC
moxonidine; oral
30.1
11.6
15
6
C03CA01
ATC
furosemide; systemic
6.2
11.6
37
97
L04AA01
ATC
[U] ciclosporin; systemic
33.3
11.1
14
5
205
Kela drug reimbursment
Chronic hypertension
6.1
11.0
35
90
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.2
11.0
48
178
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
69.4
10.9
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
12.7
10.7
19
19
B05DB
ATC
Hypertonic solutions
125.6
10.7
11
*
B05DA
ATC
Isotonic solutions
125.6
10.7
11
*
L04AD01
ATC
ciclosporin; systemic
27.7
10.7
14
6
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
10.6
10
*
H02AB04
ATC
methylprednisolone; systemic
6.6
10.3
29
63
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
10.1
42
145
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.6
9.8
27
57
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
9.6
9
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
18.4
9.4
14
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.2
9.2
18
22
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.0
9.0
33
97
Z49.2
ICD-10 Finland
Other dialysis
100.0
8.6
9
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
100.0
8.6
9
*
H05BX01
ATC
cinacalcet; oral
+∞
8.5
8
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
8.5
8
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
8.5
8
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
8.5
8
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.8
8.4
12
7
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
20.9
7.8
11
6
C02CA01
ATC
prazosin; oral
87.8
7.6
8
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
87.8
7.6
8
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.1
7.5
18
31
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
7.4
7
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
+∞
7.4
7
*
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
7.4
7
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
+∞
7.4
7
*
C07AG02
ATC
carvedilol; oral
11.6
7.3
13
13
C08CA02
ATC
felodipine; oral
9.1
7.0
14
18
ZXA00
NOMESCO Finland
Right side
3.9
6.6
30
105
R4110
NOMESCO Finland
Physiotherapy
3.7
6.6
36
144
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
75.6
6.5
7
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
6.3
6
*
V03AE03
ATC
lanthanum carbonate; oral
+∞
6.3
6
*
TK810
NOMESCO Finland
Hemofiltration
+∞
6.3
6
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
6.3
6
*
L04AX01
ATC
azathioprine; systemic
9.8
6.3
12
14
RD210
NOMESCO Finland
NA
11.3
6.3
11
11
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.9
6.0
13
19
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
10.4
6.0
11
12

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
88
12.07
32.71
10.8
2.7
12.34
16.47
umol/l
2.07
51
78
33
40
12.45
27.13
6.3
3.1
83.58
76.66
e9/l
0.23
22
29
58
161
8.32
22.87
27.5
3.6
7.38
7.40
ph
—
10
27
19
12
19.80
22.62
1.9
2.0
—
—
—
0
0
23
21
14.37
22.49
2.1
1.5
162.65
176.73
u/ml
0.11
17
11
22
21
13.54
20.85
2.6
1.7
—
—
—
0
0
51
138
7.22
20.15
10.6
3.2
1100.96
128.41
mg/l
0.55
46
89
40
86
7.57
19.87
18.9
5.1
—
—
—
0
0
35
75
7.00
17.17
27.1
9.6
—
—
—
0
0
15
11
16.16
16.31
12.8
6.6
—
—
—
0
0
15
11
16.16
16.31
1.3
1.4
—
—
—
0
0
48
148
5.81
15.75
12.5
4.0
28.81
16.28
mg/mmol
0.66
42
91
14
0
+∞
15.00
10.6
0.0
5.18
—
mmol/l
—
14
0
24
40
7.82
14.73
2.0
1.5
—
—
—
0
0
69
305
6.41
14.44
47.1
7.2
1.21
1.22
mmol/l
0.59
64
272
53
189
5.39
14.37
12.9
2.9
0.21
0.31
e6/l
0.27
46
144
15
14
12.66
14.13
2.6
2.5
—
—
—
0
0
37
101
5.52
13.68
8.6
3.0
2.92
1.87
e6/l
0.27
26
59
13
10
15.03
13.66
14.8
6.6
78.62
67.38
%
—
13
10
52
190
5.11
13.49
13.3
2.9
—
—
—
0
0
15
16
11.05
12.92
2.1
1.5
—
—
—
0
0
53
206
4.83
12.49
14.5
3.0
41.99
48.99
e6/l
0.08
46
163
57
240
4.75
11.96
13.5
5.1
—
—
—
0
0
41
138
4.62
11.47
11.0
3.9
—
—
—
0
0
30
80
5.13
11.16
2.1
1.9
—
—
—
0
0
12
12
11.38
10.68
3.7
2.3
—
—
—
0
0
14
6
27.20
10.61
1.8
1.7
—
—
—
0
0
55
245
4.20
10.24
17.7
3.6
9.98
43.93
e6/l
1.26
46
170
13
16
9.33
10.00
2.5
1.2
6.00
3.67
u/ml
—
8
9
25
63
5.11
9.84
2.7
1.7
—
—
—
0
0
26
68
4.97
9.79
18.8
9.1
23.80
24.22
mmol/l
0.29
26
68
35
119
4.18
9.40
4.5
1.7
—
—
—
0
0
47
206
3.68
8.59
10.4
5.8
—
—
—
0
0
8
0
+∞
8.46
3.3
0.0
—
—
—
0
0
31
105
3.98
8.24
4.1
3.0
365.32
545.79
ng/l
0.21
25
71
11
5
24.74
8.23
1.2
1.0
—
—
—
0
0
14
25
6.45
7.81
1.5
1.2
—
—
—
0
0
38
154
3.54
7.68
4.4
2.0
5.64
0.83
mg/l
0.97
33
121
13
22
6.74
7.61
4.1
2.3
—
—
—
0
0
65
374
3.66
7.35
14.4
5.5
1.84
2.13
e9/l
1.93
59
344
64
365
3.61
7.34
14.5
5.4
0.66
0.58
e9/l
1.58
58
327
64
365
3.61
7.34
14.5
5.4
0.04
0.04
e9/l
0.15
58
327
10
13
8.53
7.27
9.2
3.4
—
—
—
0
0
69
423
3.71
6.83
18.2
8.7
4.57
3.83
e9/l
1.20
63
378
18
46
4.64
6.82
1.8
1.3
—
—
—
0
0
20
56
4.31
6.77
27.1
10.5
1.02
1.55
mmol/l
0.24
20
44
64
376
3.43
6.77
15.3
6.2
0.20
0.20
e9/l
0.01
59
343
6
0
+∞
6.32
1.0
0.0
—
—
—
0
0
6
0
+∞
6.32
5.0
0.0
—
—
—
0
0
10
16
6.91
6.09
1.4
1.4
—
—
—
0
0
63
389
3.07
5.70
20.2
5.0
7.16
6.33
mmol/l
0.90
58
352
42
209
2.89
5.69
3.9
2.0
—
—
—
0
0
43
217
2.88
5.67
4.2
2.2
—
—
—
0
0
36
166
2.95
5.59
7.3
3.5
—
—
—
0
0
71
476
3.33
5.41
14.4
4.0
—
—
—
0
0
16
45
4.11
5.33
4.0
3.0
0.23
0.22
g/l
0.13
16
45
55
324
2.79
5.29
12.0
6.1
17.01
17.96
umol/l
0.06
55
305
5
0
+∞
5.25
5.0
0.0
—
—
—
0
0
37
183
2.74
4.94
4.5
1.8
—
—
—
0
0
54
324
2.67
4.88
26.1
7.7
0.01
0.00
e9/l
0.80
43
256
9
11
8.94
4.68
1.1
1.1
—
—
—
0
0
7
6
12.49
4.35
1.3
1.7
—
—
—
0
0
7
6
12.49
4.35
2.3
1.3
—
—
—
0
0
40
217
2.52
4.33
2.0
1.8
97.60
95.30
pmol/l
0.11
20
117
12
32
4.17
4.24
1.3
1.2
—
—
—
0
0
47
279
2.43
4.14
7.7
3.2
—
—
—
0
0
9
14
7.00
4.09
10.8
3.4
—
—
—
0
0
7
7
10.70
4.08
8.0
8.6
10.53
11.26
%
—
7
7
7
7
10.70
4.08
1.9
5.3
—
—
—
0
0
12
33
4.04
4.08
19.6
14.6
91.48
94.68
%
0.77
12
33
7
8
9.36
3.84
5.1
1.9
1.29
1.59
mmol/l
—
7
8
8
12
7.19
3.76
28.4
3.2
—
—
—
0
0
8
12
7.19
3.76
7.8
3.8
57.88
55.50
%
—
8
12
8
12
7.19
3.76
5.6
2.6
119.50
131.14
g/l
—
8
7
8
12
7.19
3.76
6.5
3.8
4.13
4.38
e9/l
—
8
12
17
63
3.09
3.74
19.4
7.0
23.45
24.56
mmol/l
0.90
17
63
53
344
2.32
3.67
10.1
3.3
0.00
0.00
estimate
0.00
11
67
10
26
4.20
3.63
38.6
16.5
—
—
—
0
0
6
6
10.59
3.55
2.0
1.5
—
—
—
0
0
37
210
2.29
3.48
20.4
6.7
1.23
1.13
inr
—
9
58
17
66
2.94
3.45
28.4
6.7
—
—
—
0
0
53
351
2.24
3.41
10.1
3.4
0.00
0.00
estimate
0.00
12
63
52
344
2.21
3.33
14.5
4.8
0.00
0.00
estimate
0.00
12
68
6
7
9.07
3.31
5.2
2.7
—
—
—
0
0
6
7
9.07
3.31
5.0
2.4
—
—
—
0
0
6
7
9.07
3.31
2.3
1.0
30.00
33.29
pg
—
6
7
9
20
4.88
3.21
3.2
3.3
—
—
—
0
0
14
53
2.94
2.95
5.3
4.7
0.72
1.17
%
—
9
12
38
238
2.03
2.65
1.6
1.6
—
—
—
0
0
5
7
7.47
2.58
2.6
1.6
—
—
—
0
0
20
98
2.34
2.56
2.4
1.3
—
—
—
0
0
12
46
2.86
2.47
3.8
4.7
1.00
0.86
%
—
7
7
14
59
2.63
2.43
12.0
20.7
—
0.99
—
0
8
7
17
4.37
2.41
1.1
1.1
—
—
—
0
0
7
18
4.12
2.30
4.3
2.4
—
—
—
0
0
5
9
5.81
2.24
1.6
1.1
—
—
—
0
0
6
14
4.51
2.19
12.8
2.9
4.68
4.88
kpa
—
6
14
6
14
4.51
2.19
12.8
2.9
9.82
8.92
kpa
—
6
14
29
180
1.90
2.00
4.8
2.2
100.38
58.03
u/l
0.48
29
172
25
148
1.95
1.97
2.0
1.8
—
—
—
0
0
28
175
1.87
1.88
4.1
2.8
—
—
—
0
0
6
19
3.31
1.69
14.0
2.8
7.40
7.44
ph
—
6
14
14
71
2.15
1.64
1.7
1.5
—
—
—
0
0
5
16
3.24
1.46
8.6
1.4
—
—
—
0
0
26
173
1.71
1.39
2.3
1.8
1.50
1.44
mmol/l
0.14
26
153
33
237
1.62
1.32
3.4
1.9
—
—
—
0
0
25
167
1.69
1.31
3.8
2.3
251.20
364.41
u/l
0.27
25
162
5
18
2.88
1.30
2.0
1.3
—
—
—
0
0
78
694
1.93
1.29
60.5
12.2
35.39
40.25
%
7.00
69
580
72
628
1.73
1.25
72.9
13.9
14.37
13.45
%
3.54
72
622
11
57
2.06
1.23
17.8
3.4
—
—
—
0
0
82
754
1.98
1.17
45.0
10.0
—
—
—
0
0
80
725
1.93
1.14
48.2
11.0
17.28
20.83
mg/l
0.95
73
556
7
31
2.36
1.13
43.0
4.5
—
—
—
0
0
80
729
1.88
1.05
53.8
11.6
182.34
71.82
umol/l
5.85
80
729
6
27
2.31
0.95
8.0
1.4
—
—
—
0
0
8
48
1.73
0.81
6.2
3.7
—
—
—
0
0
48
409
1.37
0.73
5.5
3.3
—
—
—
0
0
9
138
0.61
0.67
1.3
1.7
—
—
—
0
0
5
28
1.83
0.67
8.6
2.6
—
—
—
0
0
8
49
1.69
0.64
14.4
4.7
—
—
—
0
0
20
257
0.71
0.60
3.6
2.5
—
—
—
0
0
0
22
0.00
0.60
0.0
2.5
—
3.91
—
0
9
6
92
0.63
0.45
1.0
1.3
—
—
—
0
0
5
31
1.65
0.44
1.2
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
2.48
—
0
10
10
71
1.46
0.41
1.8
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
8.39
—
0
11
6
42
1.46
0.36
1.2
1.2
—
—
—
0
0
9
73
1.26
0.26
1.9
1.2
—
—
—
0
0
19
163
1.21
0.24
3.1
4.5
1.39
2.15
ug/l
1.09
19
146
23
202
1.19
0.23
5.7
3.8
94.76
29.85
ng/l
0.47
17
123
5
40
1.26
0.23
1.8
1.5
—
—
—
0
0
5
40
1.26
0.23
1.6
1.5
—
—
—
0
0
5
40
1.26
0.23
1.2
2.0
—
—
—
0
0
5
40
1.26
0.23
1.6
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
3.0
—
17.64
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
9.28
—
0
12
6
47
1.30
0.21
7.5
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
22
196
1.16
0.18
12.2
2.8
—
—
—
0
0
8
68
1.19
0.17
1.3
1.4
—
—
—
0
0
83
815
1.24
0.15
71.9
16.9
118.61
135.71
g/l
11.53
83
805
83
815
1.24
0.15
71.5
16.5
90.81
89.68
fl
1.17
83
805
83
815
1.24
0.15
71.3
16.4
30.04
29.99
pg
0.10
83
804
19
170
1.15
0.15
11.1
4.7
—
—
—
0
0
6
53
1.14
0.09
6.8
3.0
6.14
3.91
e9/l
—
6
45
9
86
1.05
0.07
1.4
2.2
—
—
—
0
0
19
188
1.01
0.00
1.6
1.4
2.94
2.28
g/l
0.43
11
110
16
157
1.02
0.00
5.2
3.4
—
—
—
0
0
18
179
1.01
0.00
15.2
3.5
0.00
0.02
estimate
0.49
11
66
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
6
66
0.90
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
1.54
—
0
7
0
7
0.00
0.00
0.0
4.0
—
1.27
—
0
7
0
9
0.00
0.00
0.0
7.4
—
0.63
—
0
9
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
8
79
1.01
0.00
1.1
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_NONAIHA_OTHER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_NONAIHA_OTHER.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: D3_NONAIHA_OTHER – Haemolytic-uraemic syndrome

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data